Dedicated to Finding New Medicines Through Targeting the Ubiquitin Pathway

News Headlines

Progenra receives second immune oncology patent

Progenra publishes findings on novel immune-oncology drug in eBioMedicine

Learn More >


Upcoming Meetings

Progenra CEO to give Keynote Address at the 18th Annual  Drug Discovery Leaders’ Summit associated with the Discovery Chemistry and Drug Design Congress in June in Berlin.

Learn More >


Business Development

Progenra is seeking industry partnerships for licensing opportunities surrounding the company’s small molecule portfolio Drug Discovery Platform


Learn More >